Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
109.8 USD | -0.44% | +0.67% | +10.19% |
04-30 | Moderna's Top-Line Sales Seen to Start Growing in 2025, Oppenheimer Says | MT |
04-30 | Wall Street: buoyed by Tesla, confident ahead of FOMC meeting | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.19% | 42.24B | |
-0.08% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.55% | 24.63B | |
-23.58% | 18.2B | |
+27.65% | 12.01B | |
-3.03% | 11.76B | |
+14.83% | 10.4B | |
-4.96% | 9.94B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Moderna : Barclays Adjusts Moderna's Price Target to $178 From $169, Maintains Overweight Rating